Real-world evidence in achondroplasia: considerations for a standardized data set

Area of Science:

• Medical research
• Rare disease studies
• Data science in healthcare

Background:

• Real-world evidence (RWE) collection is vital for understanding achondroplasia.
• A prospective, international data resource is needed for long-term, high-quality data capture.
• Such a resource would enhance knowledge of achondroplasia's natural history, quality of life, and outcomes.

Purpose of the Study:

• To identify essential data elements for a standardized prospective registry for achondroplasia.
• To facilitate the study of achondroplasia's natural history and related outcomes.
• To improve clinical decision-making and management strategies for achondroplasia patients.

Main Methods:

• A multidisciplinary committee (Europe, Middle East, and Africa Achondroplasia Steering Committee) was formed.
• The committee comprised 17 clinical experts and 3 patient advocacy representatives.
• An exercise was conducted to identify essential data elements for a prospective registry.

Main Results:

• Current RWE collection for achondroplasia varies in data elements, methods, and frequency across centers.
• Key areas for data collection include auxological measures, sleep studies, quality of life, and neurological manifestations.
• Essential data for a registry were categorized into demographics, diagnosis/measurements, medical issues, investigations/surgery, medications, and treatment outcomes.

Conclusions:

• Long-term, high-quality data are essential for managing rare and complex conditions like achondroplasia.
• Prospective registries collecting predefined data elements will yield valuable longitudinal information.
• A feasible minimum dataset can be established, allowing for country-specific criteria and pooled data analysis for therapeutic approaches.